Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 77,862
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12599618 | System and method for aerobic respiratory treatment | 🖼🧊📄§ | 2026-04-14 | 2043-10-09 | 0 | 31 |
| 12599608 | Methods for treating cardiac valve disease | 🖼🧊📄§ | 2026-04-14 | 2039-08-20 | 0 | 31 |
| 12599599 | Anti-inflammatory, anti-cancer, and anti-angiogenic compounds, pharmaceutical compositions, and methods of making and using thereof | 🖼🧊📄§ | 2026-04-14 | 2043-07-20 | 0 | 31 |
| 12599597 | Substituted N-benzhydrylacetamide inhibitors of jumanji domain histone demethylases for the treatment of cancer | 🖼🧊📄§ | 2026-04-14 | 2041-03-04 | 0 | 31 |
| 12599593 | Methods and compositions for treating non-ERK MAPK pathway inhibitor-resistant cancers | 🖼🧊📄§ | 2026-04-14 | 2041-12-23 | 0 | 31 |
| 12599547 | Topical compositions optimised for epidermal lipids and phosphatidyl gycerol | 🖼🧊📄§ | 2026-04-14 | 2042-02-15 | 0 | 31 |
| 12599549 | Treatment of moderate to very severe glabellar lines and lateral canthal lines | 🖼🧊📄§ | 2026-04-14 | 2040-06-05 | 0 | 31 |
| 12599552 | Cosmetic composition containing extract of Cyperus rotundus for anti-inflammation, skin soothing, irritation relief, and skin barrier enhancement | 🖼🧊📄§ | 2026-04-14 | 2043-09-08 | 0 | 31 |
| 12599557 | Liposomal sustained-release compositions containing a therapeutic drug and use thereof | 🖼🧊📄§ | 2026-04-14 | 2040-04-25 | 0 | 31 |
| 12599555 | Formulation | 🖼🧊📄§ | 2026-04-14 | 2040-09-25 | 0 | 31 |
| 12599561 | Localized immunosuppression of allografts for peripheral nerve repair | 🖼🧊📄§ | 2026-04-14 | 2042-07-05 | 0 | 31 |
| 12599563 | Pharmaceutical formulations comprising naltrexone and/or bupropion | 🖼🧊📄§ | 2026-04-14 | 2045-05-19 | 0 | 31 |
| 12599567 | Method for preparing a veterinary medicament dosage with inks and a veterinary medicament dosage obtainable by the method | 🖼🧊📄§ | 2026-04-14 | 2042-06-13 | 0 | 31 |
| 12599565 | Stable benzimidazole formulation | 🖼🧊📄§ | 2026-04-14 | 2041-10-14 | 0 | 31 |
| 12599575 | Antimicrobial adjuvant containing biphenyl derivative compound as active ingredient, and uses thereof | 🖼🧊📄§ | 2026-04-14 | 2042-01-28 | 0 | 31 |
| 12599569 | Encapsulated resveratrol (RSV) nanoparticles | 🖼🧊📄§ | 2026-04-14 | 2044-12-30 | 0 | 31 |
| 12599572 | Solid lipid nanoparticles of curcumin | 🖼🧊📄§ | 2026-04-14 | 2039-11-26 | 0 | 31 |
| 12599573 | Compositions and uses thereof in treating cancers | 🖼🧊📄§ | 2026-04-14 | 2043-03-17 | 0 | 31 |
| 12599576 | Treatment of poor metabolizers of dextromethorphan with a combination of bupropion and dextromethorphan | 🖼🧊📄§ | 2026-04-14 | 2045-07-09 | 0 | 31 |
| 12599578 | Compositions comprising enzyme-cleavable prodrugs and controlled release nafamostat and methods of use thereof | 🖼🧊📄§ | 2026-04-14 | 2042-03-08 | 0 | 31 |
| 12599577 | Thermoresponsive gel eye drop for ocular delivery of cysteamine | 🖼🧊📄§ | 2026-04-14 | 2039-11-18 | 0 | 31 |
| 12599584 | Indoline derivatives, compositions comprising them and uses thereof | 🖼🧊📄§ | 2026-04-14 | 2037-01-19 | 0 | 31 |
| 12599586 | Edaravone suspension for oral administration | 🖼🧊📄§ | 2026-04-14 | 2044-03-26 | 0 | 31 |
| 12599585 | Use of [(1R)-1-(2-chlorophenyl)-2-(tetrazol-2-yl)ethyl] carbamate in combination therapy | 🖼🧊📄§ | 2026-04-14 | 2043-04-13 | 0 | 31 |
| 12599581 | Method of treating expressive language deficit in autistic humans | 🖼🧊📄§ | 2026-04-14 | 2044-03-29 | 0 | 31 |
| 12599583 | Small molecule GRB2 stabilizers for Ras map kinase inhibition | 🖼🧊📄§ | 2026-04-14 | 2040-03-13 | 0 | 31 |
| 12599595 | Dosing regimens for the treatment of lysosomal storage diseases using pharmacological chaperones | 🖼🧊📄§ | 2026-04-14 | 2043-05-18 | 0 | 31 |
| 12599594 | Treatment of Fabry disease in ERT-naïve and ERT-experienced patients | 🖼🧊📄§ | 2026-04-14 | 2043-05-18 | 0 | 31 |
| 12599591 | Vemurafenib and salts thereof for use in the treatment of enteroviral infections | 🖼🧊📄§ | 2026-04-14 | 2039-10-03 | 0 | 31 |
| 12599590 | Veterinary formulations comprising rapamycin and methods of using the same for treating animal disease | 🖼🧊📄§ | 2026-04-14 | 2040-12-18 | 0 | 31 |
| 12599151 | Biochars, biochar extracts and biochar extracts having soluble signaling compounds and method for capturing material extracted from biochar | 🖼🧊📄§ | 2026-04-14 | 2041-08-23 | 0 | 31 |
| 12595307 | Anti-CTLA4 monoclonal antibodies and chimeric antigen receptors | 🖼🧊📄§ | 2026-04-07 | 2041-06-09 | 0 | 31 |
| 12594254 | Intranasal administration of n-acetylcysteine and uses thereof | 🖼🧊📄§ | 2026-04-07 | 2043-02-07 | 0 | 31 |
| 12594245 | Dry powder formulations for messenger RNA | 🖼🧊📄§ | 2026-04-07 | 2042-05-16 | 0 | 31 |
| 12594275 | Immunophilin binding agents and uses thereof | 🖼🧊📄§ | 2026-04-07 | 2040-02-06 | 0 | 31 |
| 12595469 | Treatment of retinitis pigmentosa using improved engineered meganucleases | 🖼🧊📄§ | 2026-04-07 | 2041-05-11 | 0 | 31 |
| 12596122 | LILRB2 antibodies and uses thereof | 🖼🧊📄§ | 2026-04-07 | 2041-01-28 | 0 | 31 |
| 12595464 | Method of producing retinal pigment epithelial cell | 🖼🧊📄§ | 2026-04-07 | 2045-02-25 | 0 | 31 |
| 12595485 | Modulation of prekallikrein (PKK) expression | 🖼🧊📄§ | 2026-04-07 | 2043-10-18 | 0 | 31 |
| 12595175 | Calcium phosphate-based core-shell structured material, method for preparing the same, and oral care composition using the same | 🖼🧊📄§ | 2026-04-07 | 2042-06-21 | 0 | 31 |
| 12595237 | Lamotrigine hydrate crystal form, preparation method therefor, and composition containing same | 🖼🧊📄§ | 2026-04-07 | 2042-04-18 | 0 | 31 |
| 12595244 | Small molecule inhibitors of mammalian SLC6A19 function | 🖼🧊📄§ | 2026-04-07 | 2045-05-30 | 0 | 31 |
| 12595251 | Amidines and amidine analogs for the treatment of bacterial infections and potentiation antibiotics | 🖼🧊📄§ | 2026-04-07 | 2039-06-13 | 0 | 31 |
| 12595269 | Morpholine-like monoamine releasers | 🖼🧊📄§ | 2026-04-07 | 2043-02-16 | 0 | 31 |
| 12595288 | Vasopressin-2 receptor antagonist peptides and uses thereof | 🖼🧊📄§ | 2026-04-07 | 2041-06-23 | 0 | 31 |
| 12595289 | Therapeutic agent for breast cancer comprising BIG3-PHB2 interaction-inhibiting peptide derived from PHB2 | 🖼🧊📄§ | 2026-04-07 | 2039-11-28 | 0 | 31 |
| 12595291 | Engineered immune cells with micro-clusters | 🖼🧊📄§ | 2026-04-07 | 2041-09-21 | 0 | 31 |
| 12595299 | FC variants | 🖼🧊📄§ | 2026-04-07 | 2041-10-05 | 0 | 31 |
| 12595297 | Methods and compositions for inhibition of EGF/EGFR pathway in combination with tyrosine kinase inhibitors | 🖼🧊📄§ | 2026-04-07 | 2036-03-17 | 0 | 31 |
| 12595306 | TREM2 stabilizing antibodies | 🖼🧊📄§ | 2026-04-07 | 2044-12-23 | 0 | 31 |